Literature DB >> 12466373

11beta-hydroxysteroid dehydrogenase types 1 and 2: an important pharmacokinetic determinant for the activity of synthetic mineralo- and glucocorticoids.

Sven Diederich1, Ekkehard Eigendorff, Patrick Burkhardt, Marcus Quinkler, Christiane Bumke-Vogt, Marina Rochel, Dieter Seidelmann, Peter Esperling, Wolfgang Oelkers, Volker Bähr.   

Abstract

The 11beta-hydroxysteroid dehydrogenase (11beta-HSD) system plays a pivotal role in glucocorticoid (GC) and mineralocorticoid (MC) action. Although 11beta-HSD activities are important determinants for the efficacy of synthetic MCs and GCs, corresponding pharmacokinetic data are scanty. Therefore, we characterized 11beta-HSD profiles for a wide range of steroids often used in clinical practice. 11beta-HSD1 and 11beta-HSD2 were selectively examined in 1) human liver and kidney cortex microsomes, and 2) Chinese hamster ovarian cells stably transfected with 11beta-HSD1 or 11beta-HSD2 expression vectors. Both systems produced concordant evidence for the following conclusions. Oxidation of steroids by 11beta-HSD2 is diminished if they are fluorinated in position 6alpha or 9alpha (e.g. in dexamethasone) or methylated at 2alpha or 6alpha (in methylprednisolone) or 16alpha or 16beta, by a methylene group at 16 (in prednylidene), methyloxazoline at 16, 17 (in deflazacort), or a 2-chlor configuration. Whereas the methyl groups also decrease reductase activity (steric effects), fluorination increases reductase activity (negative inductive effect), leading to a shift to reductase activity. This may explain the strong MC activity of 9alpha-fluorocortisol and should be considered in GC therapy directed to 11beta-HSD2-expressing tissues (kidney, colon, and placentofetal unit). 11beta-HSD2 oxidation of prednisolone is more effective than that of cortisol, explaining the reduced MC activity of prednisolone compared with cortisol. Reduction by 11beta-HSD1 is diminished by 16alpha-methyl, 16beta-methyl, 2alpha-methyl, and 2-chlor substitution, whereas it is increased by the Delta(1)-dehydro configuration in prednisone, resulting in higher hepatic first pass activation of prednisone compared with cortisone. To characterize a GC or a MC as substrate for the different 11betaHSDs may be essential for an optimized steroid therapy.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12466373     DOI: 10.1210/jc.2002-020970

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  35 in total

Review 1.  Use of prednisone with abiraterone acetate in metastatic castration-resistant prostate cancer.

Authors:  Richard J Auchus; Margaret K Yu; Suzanne Nguyen; Suneel D Mundle
Journal:  Oncologist       Date:  2014-10-31

2.  Prednisone Pharmacokinetics During Pregnancy and Lactation.

Authors:  Rachel J Ryu; Thomas R Easterling; Steve N Caritis; Raman Venkataramanan; Jason G Umans; Mahmoud S Ahmed; Shannon Clark; Ira Kantrowitz-Gordon; Karen Hays; Brooke Bennett; Matthew T Honaker; Kenneth E Thummel; Danny D Shen; Mary F Hebert
Journal:  J Clin Pharmacol       Date:  2018-05-07       Impact factor: 3.126

Review 3.  Glucocorticoid-induced osteoporosis: 2019 concise clinical review.

Authors:  G Adami; K G Saag
Journal:  Osteoporos Int       Date:  2019-02-25       Impact factor: 4.507

Review 4.  Minireview: live and let die: molecular effects of glucocorticoids on bone cells.

Authors:  Lorenz C Hofbauer; Martina Rauner
Journal:  Mol Endocrinol       Date:  2009-05-28

5.  Functional proteomic analysis of corticosteroid pharmacodynamics in rat liver: Relationship to hepatic stress, signaling, energy regulation, and drug metabolism.

Authors:  Vivaswath S Ayyar; Richard R Almon; Debra C DuBois; Siddharth Sukumaran; Jun Qu; William J Jusko
Journal:  J Proteomics       Date:  2017-03-14       Impact factor: 4.044

6.  Successful use of dexamethasone when prednisolone is not tolerated.

Authors:  V J Heazlewood; M Ratnapala; L Cochrane
Journal:  Obstet Med       Date:  2009-09-01

7.  Stickleback embryos use ATP-binding cassette transporters as a buffer against exposure to maternally derived cortisol.

Authors:  Ryan T Paitz; Syed Abbas Bukhari; Alison M Bell
Journal:  Proc Biol Sci       Date:  2016-03-16       Impact factor: 5.349

8.  Blocking the mineralocorticoid receptor improves effectiveness of steroid treatment for low back pain in rats.

Authors:  Ling Ye; Wenrui Xie; Judith A Strong; Jun-Ming Zhang
Journal:  Anesthesiology       Date:  2014-09       Impact factor: 7.892

9.  Regulation of ENaC-mediated sodium transport by glucocorticoids in Reissner's membrane epithelium.

Authors:  Sung Huhn Kim; Kyunghee X Kim; Nithya N Raveendran; Tao Wu; Satyanarayana R Pondugula; Daniel C Marcus
Journal:  Am J Physiol Cell Physiol       Date:  2009-01-14       Impact factor: 4.249

Review 10.  Antenatal endogenous and exogenous glucocorticoids and their impact on immune ontogeny and long-term immunity.

Authors:  María Emilia Solano; Megan C Holmes; Paul R Mittelstadt; Karen E Chapman; Eva Tolosa
Journal:  Semin Immunopathol       Date:  2016-07-28       Impact factor: 9.623

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.